So if actually AstraZeneca was found liable ... plus CDK4/6 inhibitor treatment who have these emerging ESR1 mutations without disease progression on clinical scan. And we estimate this to ...

The FDA posted to its site the observations made during an inspection of an AstraZeneca (AZN) manufacturing center that was conducted from May ...

AstraZeneca (AZN) is set to acquire U.S. biotech company FibroGen’s (FGEN) China unit for $160 million to expand its presence in the country.

AstraZeneca PLC ADR closed 15.81% short of its 52-week high of $87.68, which the company achieved on August 30th.

AstraZeneca announced that this week it has ... 0.11 to 0.26; P<0.001). Survival without disease recurrence at two years was 90% (95% CI 84-93) for osimertinib and 44% (95% CI 37-51) for placebo.

Pharmaceutical giant AstraZeneca announced its fourth quarter and full year 2024 earnings on Thursday. Product sales for the fourth quarter came up to $13.4 billion (€12.9bn), which was a rise ...

AstraZeneca is expanding its boot print in Canada with a $570 million investment designed to create 700 jobs. The Big Pharma has also received about $11 million from Canada’s government through ...

Pascal Soriot, chief executive of AstraZeneca, says his company has ‘very good collaboration’ with the Government and remains committed to investing in the UK - Zach Gibson/Bloomberg The boss ...

AstraZeneca (NASDAQ:AZN) is one of the biggest players in the healthcare sector, whose medicines save the lives of tens of thousands of people every year. In this article, I will share six reasons ...

The boss of AstraZeneca has denied a rift with the Government after axing plans for a £450m vaccine factory in Liverpool. Sir Pascal Soriot said it was “fake news” to suggest that tension ...

AstraZeneca announces a $570 million investment in Canada, adding 700 jobs and supporting its goal of $80 billion in revenue by 2030. AstraZeneca's Canadian investments since 2023 exceed CA$1.3 ...

700 new scientific and high-skilled jobs to be created in Greater Toronto Area, investing to execute more than 210 AstraZeneca global clinical studies MISSISSAUGA, ON, Jan. 23, 2025 /CNW ...